Atlas Trials

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Clinical trial NCT02360501 · COMPLETED

Trial details

NCT number
NCT02360501
Sponsor
Sun Yat-sen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Neoplasms
Start date
2008-01-01
Primary completion
2016-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.